Ferroptosis induction via targeting metabolic alterations in head and neck cancer

被引:8
|
作者
Lee, Jaewang [1 ,2 ]
Roh, Jong-Lyel [1 ,2 ]
机构
[1] CHA Univ, CHA Bundang Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Seongnam 13496, Gyeonggi Do, South Korea
[2] CHA Univ, Gen Grad Sch, Dept Biomed Sci, Seongnam, South Korea
基金
新加坡国家研究基金会;
关键词
Metabolism; Mitochondria; Ferroptosis; Lipid peroxidation; Head and neck cancer; SQUAMOUS-CELL CARCINOMA; CISPLATIN-RESISTANT HEAD; NASOPHARYNGEAL CARCINOMA; LIPID DROPLETS; TUMOR-GROWTH; INHIBITION; IRON; DEATH; CELECOXIB; METASTASIS;
D O I
10.1016/j.critrevonc.2022.103887
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ferroptosis is a newly regulated cell death induced by the accumulation of iron-mediated lipid peroxidation. The alteration of cancer metabolism may contribute to proliferation, metastasis, and treatment resistance in human cancers, implicating the sensitivity to ferroptosis induction. Altered metabolism in cancer cells regulates oxidative stresses and changes metabolism intermediates, contributing to their deregulated growth and prolif-eration. Cancer metabolic changes toward the elevation of cellular free iron and polyunsaturated fatty acids sensitize cancer cells to lipid peroxidation toxicity tightly linked to ferroptosis. The altered metabolism in cancers can be served as a promising target to reverse cancer therapeutic resistance by ferroptosis induction to selectively kill cancer cells while sparing normal cells. The role of mitochondria and lipid metabolism in inducing ferroptosis in head and neck cancer (HNC) has been elucidated in previous studies. Ferroptosis is receiving attention in cancer research as treating cancers altering cellular metabolism and refractory from conventional therapies. More in-depth studies are needed to develop highly therapeutic drugs and practical methods to induce ferroptosis in diverse cancer cells and tumor microenvironments effectively. Therefore, this review intends to understand the altered metabolism and find new therapeutic possibilities using ferroptosis in HNC.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Metabolic tailoring in radiotherapy for head and neck cancer
    Servagi-Vernat, S.
    Giraud, P.
    CANCER RADIOTHERAPIE, 2014, 18 (5-6): : 565 - 571
  • [42] Statin-induced metabolic reprogramming in head and neck cancer: a biomarker for targeting monocarboxylate transporters
    Manal Mehibel
    Fernando Ortiz-Martinez
    Nadine Voelxen
    Amy Boyers
    Amy Chadwick
    Brian A. Telfer
    Wolfgang Mueller-Klieser
    Catharine M. West
    Susan E. Critchlow
    Kaye J. Williams
    Ian J. Stratford
    Scientific Reports, 8
  • [43] Variable genetic alterations and survival in head and neck cancer
    Gleich, LL
    Li, YQ
    Wang, X
    Stambrook, PJ
    Gluckman, JL
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 1999, 125 (09) : 949 - 952
  • [44] Microsatellite alterations in African Americans with head and neck cancer
    Yoo, GH
    Nguyen, NX
    Du, W
    Schwartz, AG
    Land, S
    Lin, HS
    Kewson, D
    Murphy, LL
    Cilluffo, D
    Ensley, JF
    Tainsky, MA
    LARYNGOSCOPE, 2004, 114 (09): : 1619 - 1624
  • [45] Molecular techniques and genetic alterations in head and neck cancer
    Ha, Patrick K.
    Chang, Steven S.
    Glazer, Chad A.
    Califano, Joseph A.
    Sidransky, David
    ORAL ONCOLOGY, 2009, 45 (4-5) : 335 - 339
  • [46] Chromosomal alterations associated with malignancy in head and neck cancer
    Bockmuhl, U
    Wolf, G
    Schmidt, S
    Schwendel, A
    Jahnke, V
    Dietel, M
    Petersen, I
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 827 - 827
  • [47] Immune alterations and immunotherapy prospects in head and neck cancer
    Varilla, Vincent
    Atienza, Jonessa
    Dasanu, Constantin A.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (09) : 1241 - 1256
  • [48] Genomic alterations associated with malignancy in head and neck cancer
    Bockmuhl, U
    Wolf, G
    Schwendel, A
    Jahnke, V
    Dietel, M
    Petersen, I
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 1998, 20 (02): : 145 - 151
  • [49] MitoTam induces ferroptosis and increases radiosensitivity in head and neck cancer cells
    Reinema, F. V.
    Hudson, N.
    Adema, G. J.
    Peeters, W. J. M.
    Neuzil, J.
    Stursa, J.
    Werner, L.
    Sweep, F. C. G. J.
    Bussink, J.
    Span, P. N.
    RADIOTHERAPY AND ONCOLOGY, 2024, 200
  • [50] Targeting EGFR in head and neck cancer: a decade of progress
    Chris Boshoff
    Marshall Posner
    Nature Reviews Clinical Oncology, 2009, 6 : 123 - 123